SINGULAIR MRK 711
Generic Name: montelukast
Pill imprint SINGULAIR MRK 711 has been identified as Singulair 4 mg.
Singulair is used in the treatment of asthma; asthma, maintenance; copd; hay fever; bronchospasm prophylaxis and belongs to the drug class leukotriene modifiers. There is no proven risk in humans during pregnancy.
Singulair 4 mg is not subject to the Controlled Substances Act.
See also related documents.
Singulair Images
- Generic Name:
- montelukast
- Imprint:
-
SINGULAIR
MRK 711 - Strength:
- 4 mg
- Color:
- Pink
- Size:
- 11.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- mannitol
microcrystalline cellulose
hydroxypropyl cellulose
ferric oxide red
croscarmellose sodium
aspartame
magnesium stearate
- Drug Class:
- Leukotriene modifiers
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Merck & Company Inc.
- National Drug Code (NDC):
- 00006-0711
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54868-4630 | Physicians Total Care Inc (repackager) |
| 55289-0989 | PDRX Pharmaceuticals Inc (repackager) |
| 49999-0952 | Lake Erie Medical and Surgical Supply (repackager) |
Note: Inactive ingredients may vary.
More Singulair resources
- Singulair
- Singulair (Wolters Kluwer)
- Singulair Chewable Tablets (Wolters Kluwer)
- Singulair Granules (Wolters Kluwer)
- Singulair (Cerner Multum)
- Singulair (Micromedex) - Includes Dosage Information
- Singulair (AHFS DI)
- Singulair (FDA)


